Gregory Yanik is an Oncology physician affiliated with University of Michigan. OpenAlex indexes 331 publications with 16,220 citations (h-index 60); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Pediatric Hematology-Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1500 East Medical Center Dr
7th Floor C.S. Mott Childrens Hospital
Ann Arbor, MI 481094257
Telephone
734-936-9814Registry record last updated 21 Nov 2012.
Clinical trials
- Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
Sponsor: University of Michigan Rogel Cancer Center
- Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS)
Sponsor: Gregory Yanik
- Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant
Sponsor: University of Michigan Rogel Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- National Marrow Donor ProgramProgram year20252 payments
- JAZZ PHARMACEUTICALS INC.Program year20251 payment
- National Marrow Donor ProgramProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
5 NIH research awards on record, funded 2000–2025 per NIH RePORTER. The latest:
- Parametric Response Mapping (PRM) for the detection of chronic lung injury in hematopoietic cell transplant recipients
University of Michigan at Ann Arbor
FY2025$741,498R01HL162661 - BMT Core- University of Michigan Core Clinical Consortium for the BMT Clinical Trials Network (BMT CTN)
University of Michigan at Ann Arbor
FY2025$226,361UG1HL069330 - Parametric Response Mapping (PRM) for the detection of chronic lung injury in hematopoietic cell transplant recipients
University of Michigan at Ann Arbor
FY2024$727,648R01HL162661
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD
Journal of Clinical Oncology
2021 - Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Moshe Talpaz, MD
University of Michigan
William Herman, MD
University of Michigan
Max Wicha, MD
University of Michigan
Dinesh Khanna, MD
University of Michigan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”